RUNX1 anticorps (Ser435)

N° du produit ABIN7179972

L’anticorps Lapin Polyclonal anti-RUNX1 a été validé pour WB et ELISA. Il convient pour détecter RUNX1 dans des échantillons de Humain.

Aperçu rapide pour RUNX1 anticorps (Ser435) (ABIN7179972)

Antigène: RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RUNX1 est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-RUNX1 anticorps

Épitope: Ser435

Réactivité croisée: Humain, Souris

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogène: Synthesized non-phosphopeptide derived from Human AML1 around the phosphorylation site of serine 435 (S-N-S(p)-P-T).

Isotype: IgG

Information d'application

Indications d'application: WB:1:500-1:3000,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur RUNX1

Antigène: RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))

Autre désignation: RUNX1

Sujet:

Background: CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Isoform AML-1L interferes with the transactivation activity of RUNX1. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the mouse BLK promoter. Inhibits KAT6B-dependent transcriptional activation.

Miyoshi H., Proc. Natl. Acad. Sci. U.S.A. 88:10431-10434(1991).
Sacchi N., Genes Chromosomes Cancer 11:226-236(1994).
Nucifora G., Blood 81:2728-2734(1993).

Aliases: Acute myeloid leukemia 1 antibody, Acute myeloid leukemia 1 protein antibody, alpha subunit core binding factor antibody, AML 1 antibody, AML1 antibody, AML1 EVI 1 antibody, AML1 EVI 1 fusion protein antibody, Aml1 oncogene antibody, AMLCR 1 antibody, AMLCR1 antibody, CBF alpha 2 antibody, CBF-alpha-2 antibody, CBFA 2 antibody, CBFA2 antibody, Core binding factor alpha 2 subunit antibody, Core binding factor runt domain alpha subunit 2 antibody, Core-binding factor subunit alpha-2 antibody, EVI 1 antibody, EVI1 antibody, HGNC antibody, Oncogene AML 1 antibody, Oncogene AML-1 antibody, OTTHUMP00000108696 antibody, OTTHUMP00000108697 antibody, OTTHUMP00000108699 antibody, OTTHUMP00000108700 antibody, OTTHUMP00000108702 antibody, PEA2 alpha B antibody, PEA2-alpha B antibody, PEBP2 alpha B antibody, PEBP2-alpha B antibody, PEBP2A2 antibody, PEBP2aB antibody, Polyomavirus enhancer binding protein 2 alpha B subunit antibody, Polyomavirus enhancer-binding protein 2 alpha B subunit antibody, Run1 antibody, Runt related transcription factor 1 antibody, Runt-related transcription factor 1 antibody, RUNX 1 antibody, Runx1 antibody, RUNX1_HUMAN antibody, SL3 3 enhancer factor 1 alpha B subunit antibody, SL3-3 enhancer factor 1 alpha B subunit antibody, SL3/AKV core binding factor alpha B subunit antibody, SL3/AKV core-binding factor alpha B subunit antibody

UniProt: Q01196